Effect of therapy on serum thyroglobulin levels in patients with Graves' disease
- PMID: 95586
- DOI: 10.1210/jcem-46-5-747
Effect of therapy on serum thyroglobulin levels in patients with Graves' disease
Similar articles
-
Serum thyroglobulin in normal subjects and patients with hyperthyroidism due to Graves' disease: effects of T3, iodide, 131I and antithyroid drugs.Clin Endocrinol (Oxf). 1979 Dec;11(6):585-94. doi: 10.1111/j.1365-2265.1979.tb03112.x. Clin Endocrinol (Oxf). 1979. PMID: 93993 No abstract available.
-
Five years' experience with iodine-125 therapy of Graves' disease.Lancet. 1974 Jul 13;2(7872):74-7. doi: 10.1016/s0140-6736(74)91636-5. Lancet. 1974. PMID: 4136737 No abstract available.
-
[The treatment of hyperthyroidism caused by Graves' disease; a decisional approach].Ned Tijdschr Geneeskd. 1986 Aug 9;130(32):1443-50. Ned Tijdschr Geneeskd. 1986. PMID: 2430195 Dutch. No abstract available.
-
Graves' Disease.N Engl J Med. 2016 Oct 20;375(16):1552-1565. doi: 10.1056/NEJMra1510030. N Engl J Med. 2016. PMID: 27797318 Review. No abstract available.
-
Clinical practice. Graves' disease.N Engl J Med. 2008 Jun 12;358(24):2594-605. doi: 10.1056/NEJMcp0801880. N Engl J Med. 2008. PMID: 18550875 Review. No abstract available.
Cited by
-
Graves' disease: changes in TSH receptor and anti-microsomal antibodies after thyroidectomy.Clin Exp Immunol. 1988 Jun;72(3):481-5. Clin Exp Immunol. 1988. PMID: 3168323 Free PMC article.
-
Effect of therapy on the serum thyroglobulin concentration in patients with toxic diffuse goiter, toxic nodular goiter and toxic adenoma.J Endocrinol Invest. 1987 Aug;10(4):351-7. doi: 10.1007/BF03348146. J Endocrinol Invest. 1987. PMID: 2445808
-
Thyroglobulin, thyrotropin and thyrotropin binding inhibiting immunoglobulins assayed at the withdrawal of antithyroid drug therapy as predictors of relapse of Graves' disease within one year.J Endocrinol Invest. 1989 Oct;12(9):589-95. doi: 10.1007/BF03350008. J Endocrinol Invest. 1989. PMID: 2573625
-
Serum thyroglobulin is associated with orbitopathy in Graves' disease.J Endocrinol Invest. 2021 Sep;44(9):1905-1911. doi: 10.1007/s40618-021-01505-8. Epub 2021 Jan 29. J Endocrinol Invest. 2021. PMID: 33515213 Free PMC article.
-
Multi-center evaluation of the highly sensitive Abbott ARCHITECT and Alinity thyroglobulin chemiluminescent microparticle immunoassay.J Clin Lab Anal. 2022 Sep;36(9):e24595. doi: 10.1002/jcla.24595. Epub 2022 Jul 15. J Clin Lab Anal. 2022. PMID: 35837992 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources